Terconazole
Active substance: terconazole
CREAM · TERCONAZOLE 4 mg/g
United StatesActive
Marketing holder: E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TERCONAZOLE · 4 mg/g
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-683f-7040-bb5f-7fc4f48dfe1c,01a1208d-29ac-7719-9cc7-223d0d335647,01a12091-91c8-7195-88db-d7d0a2f629f7,01a12091-af45-7884-a642-3a725de2aac1,01a12091-c7e8-72a2-bb5a-97428d82b809;count=12 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0168-0346
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- VAGINAL
Sources
- product · openFDA NDC · 0168-0346 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0168-0346 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0168-0346 · Verified 2026-10-09 · open in source